Collective, Data, History and Therapy - Medical Cannabis Brief

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. We are excited to explore the potential of emergent psychedelic therapies. ABOUT SANTÉ CANNABIS.

Clinical Trials

Clinical Trials Therapy Research and Development Events

Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ 2.0 COVID-19 Assay and Linea™ Unsupervised At-Home Sample Collection Kit

Cannabis Law Report

JANUARY 21, 2022

Assay”) and Linea™ Unsupervised At-Home Sample Collection Kit (the “Linea Collection Kit”). The Linea Collection Kit is designed to enable the simple self-collection of nasal swab specimens without supervision by medical personnel. COVID-19 Assay (the “Linea 2.0 The Linea 2.0

Collective

Collective Therapy Research and Development Supply Chain

Applied DNA Awarded Suffolk County Community College COVID-19 Testing Contract

Cannabis Law Report

SEPTEMBER 2, 2021

The Contract contains no minimum testing requirement; it stipulates a fixed monthly fee for sample collection site services and a separate fixed fee per individual COVID-19 test. The initial Contract term is one year and includes two one-year options for renewal exercisable at the College’s discretion.

Clinical Trials

Clinical Trials Research and Development Therapy Collective

Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract

Cannabis Law Report

AUGUST 3, 2021

Testing under the Contract will commence in early August 2021, and all sample collection sites will be fully operational before the start of the academic year on August 25. Applied DNA is also the manufacturer of the EUA-authorized Linea™ COVID-19 Assay Kit.

Clinical Trials

Clinical Trials Therapy Collective Research and Development

Press Release: MindMed Engages in Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring System

Cannabis Law Report

DECEMBER 9, 2021

These describe technology and infrastructure for the collection of precise, multimodal, multivalent data that can be processed via machine learning, artificial intelligence, signal processes, and other statistical methods to yield clinically meaningful output to satisfy the requirements of the IFU. NEW YORK , Dec.

Research and Development

Research and Development Clinical Trials Therapy Medicine

Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance Testing

Cannabis Law Report

JUNE 2, 2021

Samples will be collected via anterior nasal swabs that offer ease-of-use for all ages. Pooled surveillance testing of all campers will be conducted prior to the start of each of two summer sessions and once on-site.

Clinical Trials

Clinical Trials Therapy Research and Development Collective

Applied DNA Receives New York State Department of Health Conditional Approval for Linea™ 2.0 COVID-19 Assay as Laboratory Developed Test

Cannabis Law Report

JANUARY 4, 2022

Assay and Recently Developed, Unsupervised, At-Home Sample Collection Kit to Expand Addressable Market and Scope of COVID-19 Testing Services – STONY BROOK, N.Y.–(BUSINESS Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. Assay (the “Linea 2.0 Assay (the “Linea 2.0

Conditions

Conditions Research and Development Therapy Supply Chain

Applied DNA Announces Continued Momentum in COVID-19 Testing Demand

Cannabis Law Report

JANUARY 18, 2022

ADCL’s safeCircle program is a fully integrated testing platform for enterprise and educational institutions that provides a full range of COVID-19 diagnostic testing and associated services, including sample collection, test site infrastructure design and management, results tracking, and vaccination status management. Dr. James A.

Research and Development

Research and Development Therapy Supply Chain Collective

Applied DNA Implements safeCircle™ COVID-19 Testing Program at Sarah Lawrence College

Cannabis Law Report

OCTOBER 12, 2021

Mary Hartnett, Director of Medical Services at Sarah Lawrence College, stated, “safeCircle was our choice given the convenience of its on-site sample collection process, access to high-sensitivity RT-PCR-based testing with rapid turnaround times, ability to scale with our needs, and capacity to ease our administrative burdens.

Programs

Programs Clinical Trials Research and Development Therapy

Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ SARS-CoV-2 Mutation Panel

Cannabis Law Report

OCTOBER 25, 2021

The test is also intended for use with anterior nasal swab specimens that are self-collected in the presence of an HCP from individuals without symptoms or other reasons to suspect COVID-19 when tested at least weekly and with no more than 168 hours between serially collected specimens.

Research and Development

Research and Development Therapy Collective Treatment

Applied DNA and CLEARED4 Offer Fast, Cost-Effective and Turnkey Integrated Solution for Compliance with OSHA Mandate for COVID-19 Vaccination and Testing

Cannabis Law Report

NOVEMBER 5, 2021

Sample collection for weekly COVID-19 pooled testing can be performed in-person (supervised) or via self-collection kits 1. 1 Availability of self-collection kits is subject to pending regulatory approval. Tests results are returned within 24 hours of sample receipt at ADCL. About Applied DNA Sciences.

Compliance

Compliance Compliance Research and Development Therapy

Dalrada Corporation Expands Presence in Top Three Growth Industries: Clean Energy, Healthcare, Technology (IT)

Cannabis Law Report

DECEMBER 21, 2021

This calendar year marks a synchronous period in Dalrada’s history when its impactful innovations and solutions of all its subsidiaries expanded market presence into the top three largest growing industries : clean energy, healthcare, and technology. Workforce – Analyst data reveals that the employment rate at 4.6% (Oct.

Research and Development

Research and Development Supply Chain Data Business

Legal Framework for the Use of Psychedelics in Switzerland

Cannabis Law Report

JULY 24, 2022

analyse the history and applications of psychedelic substances such as LSD, psilocybin, MDMA and mescaline. The market research company Data Bridge Market Research projects that the market capitalization of the psychedelic industry will grow 16.8 Data Bridge Market Research , (last viewed 13 July 2022). [2] billion by 2029. [1]

Research and Development

Research and Development Legalization Treatment Patients

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. At the same time, the outlook on cannabis research data is largely positive. It also has an extensive and diverse history of medicinal use.

Research and Development

Research and Development Medicine Access Media

Lighting Up Florida’s Medical Marijuana People: The Medics Series, Part 6

Cannabis Law Report

JULY 30, 2019

Most importantly, as participants in the state’s cannabis-collective experience, all patients ultimately choose a physician based on the ability of a mere 2,300 certified licensed doctors to see the sheer number of Florida patients, now past 300,000 active cardholders. . org- A Brief History of Cannabis in the United States. .

Marijuana

Marijuana Patients Research and Development Programs

Jones Day: The life sciences regulatory regime in Australia

Cannabis Law Report

OCTOBER 26, 2019

The TGA does not evaluate any data relating to the trial. doctors, dentists, radiographers, nurses, pharmacists and psychologists) for patients who do not fit the Category A definition and where the UTG is not deemed to have an ‘established history of use’ Approval from the TGA is required before the UTG may be accessed.

Clinical Trials

Clinical Trials Medicine Research and Development Compliance

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

JUNE 4, 2021

He is the creator and director of the television series Hamilton’s Pharmacopeia, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs. Brian Muraresku is the New York Times Bestselling author of The Immortality Key: The Secret History of the Religion with No Name. Truffles Therapy.

Research and Development

Research and Development Medicine Treatment Pharmaceutical

Medical Cannabis Brief

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ 2.0 COVID-19 Assay and Linea™ Unsupervised At-Home Sample Collection Kit

Trending Sources

Applied DNA Awarded Suffolk County Community College COVID-19 Testing Contract

Applied DNA Awarded The City University of New York (CUNY) COVID-19 Testing Contract

Press Release: MindMed Engages in Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring System

Applied DNA Adds First Summer Camp for safeCircle Pooled COVID-19 Surveillance Testing

Applied DNA Receives New York State Department of Health Conditional Approval for Linea™ 2.0 COVID-19 Assay as Laboratory Developed Test

Applied DNA Announces Continued Momentum in COVID-19 Testing Demand

Applied DNA Implements safeCircle™ COVID-19 Testing Program at Sarah Lawrence College

Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ SARS-CoV-2 Mutation Panel

Applied DNA and CLEARED4 Offer Fast, Cost-Effective and Turnkey Integrated Solution for Compliance with OSHA Mandate for COVID-19 Vaccination and Testing

Dalrada Corporation Expands Presence in Top Three Growth Industries: Clean Energy, Healthcare, Technology (IT)

Legal Framework for the Use of Psychedelics in Switzerland

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Lighting Up Florida’s Medical Marijuana People: The Medics Series, Part 6

Jones Day: The life sciences regulatory regime in Australia

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Stay Connected